Serologiczne roznicowanie zwierzat szczepionych od zakazonych wirusem pryszczycy

• Autorzy: Niedbalski W , Kesy A.
• Języki publikacji: PL

Abstrakty

EN

Foot-and-mouth disease (FMD) is a severe and highly infectious viral disease of cloven-hoofed animals. Differentiating FMDV-infected animals from those that have merely been vaccinated is important for international and local trade of live animals, FMD control programs and in particular for eradication campaigns where emergency vaccinations have been applied. Several diagnostic tests have been developed to distinguish between these animals and are all based on detecting antibodies for non-structural proteins (NSPs) of FMDV. These assays have been described using either panels of proteins or individual proteins 3D, 2C, 3AB1 or 3ABC. The response to 3ABC and its cleavage products (mainly 3AB, 3A and 3B) seem to be the most reliable indices of infection. There are four commercially available tests for antibodies to FMDV NSPs: CHEKIT FMD-3ABC (Bommeli AG, Switzerland), Ceditest FMDV-NS (Cedi-Dignostics, B.V. the Netherlands), SVANOIR FMDV 3ABC-Ab ELISA (Svanova Biotech AB, Sweden) as well as UBI FMDV NSP ELISA (United Biomedical, Inc., USA). These kits have been validated to some extent but need to be harmonized and standardized against a set of standards which should cover different epidemiological situations.

Słowa kluczowe

PL

badania serologiczne; pryszczyca; markery zakazenia; zwierzeta zakazone; zwierzeta szczepione; przeciwciala dla NSPs; bialka niestrukturalne wirusa pryszczycy; choroby zwierzat; metody; wykrywanie

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2006
• Tom: 62
• Numer: 01
• Opis fizyczny: s.20-23,rys.,bibliogr.

Twórcy

autor

Niedbalski W

• Zaklad Pryszczycy Panstwowego Instytutu Weterynaryjnego, ul. Wodna 7, 98-220 Zdunska Wola

autor

Kesy A.

Bibliografia

• 1.Anon.: Council directive on community measures for the control of FMD repealing Directive 85/511/EEC and Decision 89/531/EEC and 91/665/EEC and amending Directive 92/46/EEC.
• 2.Belsham G. J.: Distinctive features of foot-and-mouth disease wirus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure. Prog. Biophys. Molec. Biol. 1993, 60, 241-260.
• 3.Berger H. G., Straub O. C., Ahl R., Tesar M., Marquardt O.: Identification of foot-and-mouth diasese virus replication in vaccinated cattle by antibodies to non-structural proteins. Vaccine 1990, 8, 213-216.
• 4.Bergmann I. E., Aule de Mello P., Neitzert E., Beck E., Gomes I.: Diagnosis of persistent aphtovirus infection and ist differentiation from vaccination response in cattle by use of enzyme-linked immunotransfer blot analysis with bioenergineered nonstructural viral antigens. Am. J. Vet. Res. 1993, 54, 825-831.
• 5.Bergman I. E., Malirat V., Neitzert E., Beck E., Panizzutti N., Sanchez C., Falczuk A.: Improvement of a serodiagnostic strategy for foot-and-mouth disease virus surveillance in cattle under systematic vaccination: a combined system of an indirect ELISA-3ABC with an enzyme-linked immunoelectrotransfer blot assay. Arch. Virol. 2000, 145, 473-489.
• 6.Clavijo A., Wright P., Kitching P.: Development in diagnostic techniques for differentiating infection from vaccination in foot-and-mouth disease. Vet. J. 2004, 167, 9-22.
• 7.Clercq K. De, Brocchi E., Grazioli S., Bergmann I., Paton D., Dekker A., Yadin H., Haas B., Sorensen K., Bulut N., Sammin D., Malirat V., Neitzert E., Parida S., Goris N., Tjornehoj K., Giovanni A., De Simone F.: Report of workshop on validation of NSP-ELISAs: a comparison of 6 assays. Report of the session of the research group of the standing technical committee of the European Commission for the control of foot-and-mouth disease, Chania, (Crete), Greece 12-15 October 2004, s. 56-65.
• 8.Diego M. De, Brocchi E., Mackay D., De Simone F.: The non-structural polyprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle. Arch. Virol. 1997, 142, 2021-2033.
• 9.Donaldson A.: Informal review of world Foot-and-mouth disease situation. Report of the sixty-sixth Session of the Executive Committee of the European Commission for the Control of Foot-and-Mouth Disease, Heelsum, the Netherlands, 15-16 November 2001, s. 24-27.
• 10.Lubroth J., Brown F.: Identification of native foot-and-mouth disease virus non-structural protein 2C as a serological indicator to differentiate infected from vaccinated livestock. Res. Vet. Sci. 1995, 59, 70-78.
• 11.Mackay D. K. J., Forsyth M. A., Davies P. R., Berlinzani A., Belsham G. J., Flint M., Ryan M. D.: Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, non-structural proteins in ELISA. Vaccine 1998, 16, 446-459.
• 12.Mackay D. K. J.: Differentiating infection from vaccination in foot-and-mouth disease. Vet. Q. 1998, 20, 20-24.
• 13.Moonen P., van der Linde E., Chenard G., Dekker A.: Comparable sensitivity and specificity in three commercially available ELISAs to differentiate between cattle infected with or vaccinated against foot-and-mouth disease virus. Vet. Mirobiol. 2004, 99, 93-101.
• 14.O'Donnell V. K., Smitsaart E. N., Cetra B., Duffy S., Finelli J., Boyle D., Draghi G., Fondevila N., Schudel A. A.: Detection of virus infection-associated antigen and 3D antibodies in cattle vaccinated against foot-and-mouth disease. Rev. Sci. Tech. Off. Epiz. 1997, 16, 833-840.
• 15.Paton D. J., Parida S., Anderson J.: Detection of FMD infection in vaccinated animals. Report of the session of the research group of the standing technical committee of the European Commission for the control of foot-and-mouth disease, Gerzensee, Berne, Switzerland 16-19 September 2002, s. 44-51.
• 16.Pluimers F. H.: Eradication of foot-and-mouth in the Netherlands by emergency vaccination and the trade implications. Rep. conf. Foot-and-mouth disease. Control strategies, Lyon, France 2-5 June 2002, s. 63.
• 17.Rodriquez A., Dopazo J., Saiz J. C., Sobrino F.: Immunogenicity of nonstructural proteins of foot-and-mouth disease virus: differences between infected and vaccinated swine. Arch. Virol. 1994, 136, 123-131.
• 18.Salt J.: Vaccination against FMD, [w:] Pastoret P. P., Blancou J., Vannier P., Verschueren C.: Veterinary Vaccinology. Elsevier, Amsterdam 1997, 641-649.
• 19.Schen F., Chen P. D., Walfield A. M., Ye J., House J., Brown F., Wang C. Y.: Differentiation of convalescent animals from those vaccinated against foot-and-mouth disease by a peptide ELISA. Vaccine 1999, 17, 3039-3049.
• 20.Silberstein E., Kaplan G., Taboga O., Duffy S., Palma E.: Foot-and-mouth disese virus-infected but not vaccinated cattle develop antibodies against recombinant 3AB1 nonstructural protein. Arch. Virol. 1997, 142, 795-805.
• 21.Sorensen K. J., Madsen G. K., Madsen E. S., Salt J. S., Nqindi J., Mackay D. K. J.: Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-structural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus. Arch. Virol. 1998, 143, 1461-1476.
• 22.Strebel K., Beck E., Strohmaier K., Schaller H.: Characterization of foot-and-mouth disease virus gene products with antisera against bacterially synthesized fusion proteins. J. Virol. 1986, 57, 983-991.
• 23.Tesar M., Berger H. G., Marquardt O.: Serological probes for some foot-and-mouth disease nonstructural proteins. Virus Genes 1989, 3, 29-44.
• 24.Valarcher J.-F., Knowles N., Fernandez R., Davies P., Midgley R., Hutchings G., Newman B., Ferris N., Paton D.: Global FMD situation 2003-2004. Report of the session of the research group of the standing technical committee of the European Commission for the control of foot-and-mouth disease, Chania (Crete), Greece 12-15 October 2004, s. 137-148.